These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30789956)

  • 1. Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression.
    Nociti V; Santoro M; Quaranta D; Losavio FA; De Fino C; Giordano R; Palomba NP; Rossini PM; Guerini FR; Clerici M; Caputo D; Mirabella M
    PLoS One; 2019; 14(2):e0212906. PubMed ID: 30789956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression.
    Nociti V; Santoro M; Quaranta D; Losavio FA; De Fino C; Giordano R; Palomba NP; Rossini PM; Guerini FR; Clerici M; Caputo D; Mirabella M
    PLoS One; 2018; 13(10):e0206140. PubMed ID: 30352103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Association of serum BDNF levels and the BDNF Val66Met polymorphism with the sleep pattern in healthy young adults.
    Saitoh K; Furihata R; Kaneko Y; Suzuki M; Takahashi S; Uchiyama M
    PLoS One; 2018; 13(8):e0201994. PubMed ID: 30071105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF rs6265 methylation and genotype interact on risk for schizophrenia.
    Ursini G; Cavalleri T; Fazio L; Angrisano T; Iacovelli L; Porcelli A; Maddalena G; Punzi G; Mancini M; Gelao B; Romano R; Masellis R; Calabrese F; Rampino A; Taurisano P; Di Giorgio A; Keller S; Tarantini L; Sinibaldi L; Quarto T; Popolizio T; Caforio G; Blasi G; Riva MA; De Blasi A; Chiariotti L; Bollati V; Bertolino A
    Epigenetics; 2016; 11(1):11-23. PubMed ID: 26889735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protective effect of the BDNF Met/Met genotype in obesity in healthy Caucasian subjects but not in patients with coronary heart disease.
    Sustar A; Nikolac Perkovic M; Nedic Erjavec G; Svob Strac D; Pivac N
    Eur Rev Med Pharmacol Sci; 2016 Aug; 20(16):3417-26. PubMed ID: 27608901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression.
    Romme Christensen J; Börnsen L; Ratzer R; Piehl F; Khademi M; Olsson T; Sørensen PS; Sellebjerg F
    PLoS One; 2013; 8(3):. PubMed ID: 29294474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
    Xie B; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
    J Alzheimers Dis; 2017; 58(1):263-274. PubMed ID: 28387675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington's Disease.
    Giampà C; Montagna E; Dato C; Melone MA; Bernardi G; Fusco FR
    PLoS One; 2016; 11(11):e0166102. PubMed ID: 27880782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial.
    Charvet LE; Yang J; Shaw MT; Sherman K; Haider L; Xu J; Krupp LB
    PLoS One; 2018; 13(1):e0192317. PubMed ID: 29381774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.
    Azami M; YektaKooshali MH; Shohani M; Khorshidi A; Mahmudi L
    PLoS One; 2019; 14(7):e0219466. PubMed ID: 31287842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice.
    Milani M; Laranjeira AB; de Vasconcellos JF; Brandalise SR; Nowill AE; Yunes JA
    PLoS One; 2015; 10(7):e0134774. PubMed ID: 26230098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Predicting Response Trajectories during Cognitive-Behavioural Therapy for Panic Disorder: No Association with the BDNF Gene or Childhood Maltreatment.
    Santacana M; Arias B; Mitjans M; Bonillo A; Montoro M; Rosado S; Guillamat R; Vallès V; Pérez V; Forero CG; Fullana MA
    PLoS One; 2016; 11(12):e0167833. PubMed ID: 27907177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors.
    Amato MP; Prestipino E; Bellinvia A; Niccolai C; Razzolini L; Pastò L; Fratangelo R; Tudisco L; Fonderico M; Mattiolo PL; Goretti B; Zimatore GB; Losignore NA; Portaccio E; Lolli F
    PLoS One; 2019; 14(11):e0225494. PubMed ID: 31725815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Empirical mode decomposition processing to improve multifocal-visual-evoked-potential signal analysis in multiple sclerosis.
    PLOS ONE Staff
    PLoS One; 2018; 13(5):e0196928. PubMed ID: 29715325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: The Omega-3 Fatty Acid Eicosapentaenoic Acid Accelerates Disease Progression in a Model of Amyotrophic Lateral Sclerosis.
    Yip PK; Pizzasegola C; Gladman S; Biggio ML; Marino M; Jayasinghe M; Ullah F; Dyall SC; Malaspina A; Bendotti C; Michael-Titus A
    PLoS One; 2024; 19(7):e0307246. PubMed ID: 38990842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
    Chrobok NL; Bol JGJM; Jongenelen CA; Brevé JJP; El Alaoui S; Fidalgo-Lopez J; Fournet G; Joseph B; Wilhelmus MMM; Drukarch B; van Dam AM
    PLoS One; 2018; 13(12):e0209522. PubMed ID: 30543718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Adipose-Derived Stem Cells Stimulate Regeneration of Peripheral Nerves: BDNF Secreted by These Cells Promotes Nerve Healing and Axon Growth De Novo.
    Lopatina T; Kalinina N; Karagyaur M; Stambolsky D; Rubina K; Revischin A; Pavlova G; Parfyonova Y; Tkachuk V
    PLoS One; 2019; 14(7):e0219946. PubMed ID: 31299059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease.
    Chiba H; Kakuta Y; Kinouchi Y; Kawai Y; Watanabe K; Nagao M; Naito T; Onodera M; Moroi R; Kuroha M; Kanazawa Y; Kimura T; Shiga H; Endo K; Negoro K; Nagasaki M; Unno M; Shimosegawa T
    PLoS One; 2019; 14(2):e0212148. PubMed ID: 30721250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Aberrant DNA Methylation: Implications in Racial Health Disparity.
    Wang X; Ji P; Zhang Y; LaComb JF; Tian X; Li E; Williams JL
    PLoS One; 2016; 11(6):e0158251. PubMed ID: 27326861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor.
    Zivadinov R; Weinstock-Guttman B; Benedict R; Tamaño-Blanco M; Hussein S; Abdelrahman N; Durfee J; Ramanathan M
    Hum Mol Genet; 2007 Nov; 16(22):2659-68. PubMed ID: 17656372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.